NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.4420
+0.0188 (4.44%)
Aug 4, 2026, 10:19 AM EDT - Market open
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $4.04 million as of August 4, 2026. Its market cap has decreased by -80.53% in one year.
Market Cap
4.04M
Enterprise Value
7.94M
1-Year Change
-80.53%
Ranking
Category
Stock Price
$0.44
ChartMarket Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $4.04M, a decrease of -79.40%. That is a compound annual growth rate of -28.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.04M | -69.22% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nephros | 36.80M |
| Milestone Scientific | 35.14M |
| Harvard Bioscience | 27.51M |
| Retractable Technologies | 19.76M |
| Jin Medical International | 15.50M |
| Bionano Genomics | 12.28M |
| Regentis Biomaterials | 9.01M |
| Femasys | 8.64M |